Oral administration of US FDA approved DPP-4 inhibitors, such as Saxagliptin, Vildagliptin, Anagliptin, etc., prolongs the half-lives and thus the action of GLP-1 and GIP, which in turn improves glycemic control with minimal risk of hypoglycemia (Havale and Pal, 2009)
Ludvik B, Giorgino F, Jodar E, Frias JP, Fernandez Lando L, Brown K
BPC-157 (15 aminocidos, ~1.419 Da) modula el sistema del xido ntrico, las prostaglandinas y la sealizacin de factores de crecimiento, con relevancia particular en tendones, ligamentos y tejido digestivo
Practical guidance on subcutaneous injection technique, dose titration schedules, and management of the most common side effect of transient nausea is provided
Ultimately, whether sarcosine supplementation can be harnessed to target some of the deleterious manifestations of LC through stimulation of autophagy (55) is an intriguing potential therapy to explore further
3 1